Michael Haerter

Title: Michael Haerter: Innovator in Immuno-Modulation

Introduction

Michael Haerter is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of immuno-modulation through his innovative research and development. His work has implications for the treatment of various diseases, showcasing the importance of scientific advancements in medicine.

Latest Patents

One of Michael Haerter's key patents is titled "Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments." This invention relates to sulphoximine-substituted quinazoline derivatives of the formula (I), detailing processes for their preparation and their application as a medicament for treating various diseases. He holds 1 patent in this area, reflecting his focused expertise.

Career Highlights

Throughout his career, Michael has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to contribute to significant advancements in medical research and product development.

Collaborations

Michael has collaborated with esteemed colleagues such as Arne Von Bonin and Anne Mengel. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Michael Haerter's contributions to immuno-modulation through his patented inventions and collaborations with leading companies and professionals highlight his role as a significant figure in the field of medical innovation. His work continues to pave the way for advancements in treatment options for various diseases.